Overview
Influenza rapid antigen tests detect viral nucleoprotein antigens from respiratory specimens using immunoassay formats.
Clinical Importance
Provide rapid influenza screening when NAAT turnaround is not available
Support infection-control cohorting decisions with awareness of limited sensitivity
Specimen Requirements
- Specimen: nasopharyngeal swab preferred for many kits; nasal swab/wash per manufacturer
- Collect early after symptom onset for best yield
- Follow kit transport and timing limits strictly
Analytical Method
Immunochromatographic or fluorescence immunoassay detects influenza A and/or B antigens. Negative results do not reliably exclude influenza; confirm with NAAT when clinical decisions depend on accuracy.
Instruments Used
Automated analyzers
- Laboratory immunoassay analyzers for selected antigen/toxin assays
- Cartridge / lateral-flow readers (method-dependent)
- Cepheid GeneXpert molecular platforms
- BioFire FilmArray / syndromic multiplex PCR platforms
Manual methods
- Manual EIA / lateral-flow immunochromatographic antigen tests
- Manual toxin immunoassays read visually
Reference Values
Microbiology results are interpreted against organism identification, specimen quality, clinical context, and current CLSI and/or EUCAST interpretive criteria (including CLSI M100 for susceptibility where adopted). Reporting conventions and critical-notification lists are institution-defined; verify against the performing laboratory SOP and current guideline editions.
Expected: antigen not detected. Performance varies by kit, prevalence, and specimen quality; interpret with local validation data.
Interpretation
Common Causes of Increased Results
- Antigen detected; supports influenza A or B infection (type as reported by kit)
Common Causes of Decreased Results
- Antigen not detected; false negatives common; pursue NAAT if influenza remains likely
Clinical Significance
- Outpatient and ED rapid screening
- Adjunct when molecular capacity is constrained
Factors Affecting Results
Pre-analytical
- Late sampling after symptom onset
- Wrong swab type
Analytical
- Known limited sensitivity of many RIDTs vs RT-PCR
Post-analytical
- Using a negative RIDT to stop antiviral consideration when suspicion is high
Advantages and Limitations
Advantages
- Fast
- Simple
Limitations
- Inferior sensitivity to NAAT
- Does not replace molecular testing for definitive diagnosis in many settings
Clinical Pearls
Treat RIDT as a rule-in helper in season; never as a rule-out when the patient looks like influenza.
References
Authoritative textbooks, guidelines, and reviews supporting this laboratory test reference. Verify reference intervals, critical limits, and method details against institutional protocols and current guideline editions.
Textbooks
- Carroll KC, Pfaller MA, Landry ML, et al., eds. Manual of Clinical Microbiology. ASM Press (verify current edition).
- Forbes BA, Sahm DF, Weissfeld AS. Bailey & Scott's Diagnostic Microbiology. 15th ed. Elsevier; 2020.
- Mahon CR, Lehman DC, Manuselis G. Textbook of Diagnostic Microbiology. 6th ed. Elsevier; 2018.
- Carroll KC, Hobden JA, Miller S, et al. Jawetz, Melnick, & Adelberg's Medical Microbiology. 28th ed. McGraw-Hill; 2019.
- Murray PR, Rosenthal KS, Pfaller MA. Medical Microbiology. 9th ed. Elsevier; 2021.
CLSI and Professional Guidelines
- Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. CLSI document M100 (verify current edition and institutional adoption).
- Centers for Disease Control and Prevention / NIH. Biosafety in Microbiological and Biomedical Laboratories (BMBL). Current edition (verify institutional adoption).
WHO Publications
- World Health Organization. Laboratory and diagnostic guidance relevant to clinical microbiology practice (verify current WHO publication for the method).
Frequently Asked Questions
Common questions about using this Influenza Rapid Test laboratory test Medical Laboratory Library reference in Medical Laboratory Science education.
What is the Influenza Rapid Test laboratory test reference used for?
This Medical Laboratory Library page summarizes the clinical importance of Influenza Rapid Test. Review the Clinical Importance section for why the test is ordered in laboratory medicine practice.
Where can I find Influenza Rapid Test specimen requirements?
See the Specimen Requirements section on this page for specimen information related to Influenza Rapid Test. Confirm collection details against your laboratory protocol.
Where are Influenza Rapid Test reference values listed?
See the Reference Values section on this Laboratory Library page. Reference ranges can vary by method and population, so verify intervals with your laboratory.
How do I interpret Influenza Rapid Test results?
Use the Interpretation section for laboratory interpretation framing, including increased and decreased result patterns when provided. Do not treat educational text as a patient-specific diagnosis.
What analytical method is used for Influenza Rapid Test?
See the Analytical Method section for principle and method notes. Method details may differ by instrument and institutional SOP.
Are related laboratory tests linked from Influenza Rapid Test?
Yes. The Related Laboratory Tests section lists connected references for continued lookup in the Medical Laboratory Library.
How can I continue learning after reading Influenza Rapid Test?
Use Continue learning links on this page for related Academy lessons, medical laboratory quizzes, or laboratory case studies when available for this Medical Microbiology topic.
What are the clinical pearls for Influenza Rapid Test?
See the Clinical Pearls section for concise laboratory practice notes associated with Influenza Rapid Test. Apply pearls alongside institutional protocols.
Reading progress
Awards XP once after you have meaningfully reviewed this article.